Most Profitable Pharmaceuticals Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
144.07 B
 0.08 
 1.21 
 0.10 
2NVO Novo Nordisk AS
100.99 B
(0.07)
 3.38 
(0.23)
3RDY Dr Reddys Laboratories
55.68 B
(0.07)
 1.56 
(0.11)
4MRK Merck Company
17.12 B
(0.10)
 1.76 
(0.17)
5JNJ Johnson Johnson
14.07 B
 0.11 
 1.18 
 0.13 
6NVS Novartis AG ADR
11.94 B
 0.07 
 1.29 
 0.09 
7LLY Eli Lilly and
10.59 B
 0.14 
 1.82 
 0.25 
8AZN AstraZeneca PLC ADR
8.69 B
 0.18 
 1.24 
 0.23 
9PFE Pfizer Inc
8.03 B
 0.07 
 1.36 
 0.10 
10SNY Sanofi ADR
5.5 B
 0.13 
 1.54 
 0.20 
11GSK GlaxoSmithKline PLC ADR
4.93 B
 0.12 
 1.85 
 0.22 
12ZTS Zoetis Inc
2.5 B
(0.04)
 1.54 
(0.06)
13RPRX Royalty Pharma Plc
1.33 B
 0.22 
 1.95 
 0.43 
14OGN Organon Co
1.02 B
 0.03 
 2.67 
 0.08 
15JAZZ Jazz Pharmaceuticals PLC
414.83 M
 0.15 
 1.42 
 0.22 
16PBH Prestige Brand Holdings
209.34 M
 0.04 
 2.30 
 0.09 
17INVA Innoviva
179.72 M
(0.10)
 0.88 
(0.09)
18AMPH Amphastar P
137.54 M
(0.29)
 1.90 
(0.55)
19HRMY Harmony Biosciences Holdings
128.85 M
 0.03 
 2.64 
 0.09 
20CORT Corcept Therapeutics Incorporated
106.14 M
 0.04 
 3.59 
 0.14 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.